Peringatan Keamanan

The signs and symptoms that are produced after the acute overdosage of Propylhexidrine include Psychosis, Burning sensation.

Propylhexedrine

DB06714

small molecule approved

Deskripsi

Propylhexedrine is an alpha-adrenergic agonist often used in nasal decongestant inhalers. It is used to give temporary relief for nasal congestion from colds, allergic rhinitis, or allergies.

Struktur Molekul 2D

Berat 155.2804
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

148 Data
Benzylpenicilloyl polylysine Propylhexedrine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.
Spironolactone The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Spironolactone.
Methysergide Methysergide may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Cabergoline Cabergoline may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Dihydroergotamine Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Methylergometrine Methylergometrine may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Lisuride Lisuride may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Ergotamine Ergotamine may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Nicergoline Nicergoline may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Ergoloid mesylate Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Pergolide Pergolide may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Bromocriptine Bromocriptine may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Ergometrine Ergometrine may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Lysergic acid diethylamide Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Dihydroergocornine Dihydroergocornine may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Dihydroergocristine Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Dihydroergocryptine Dihydroergocryptine may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Terguride Terguride may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Metergoline Metergoline may increase the hypertensive and vasoconstricting activities of Propylhexedrine.
Venlafaxine Venlafaxine may increase the tachycardic activities of Propylhexedrine.
Duloxetine Duloxetine may increase the tachycardic activities of Propylhexedrine.
Sibutramine Sibutramine may increase the tachycardic activities of Propylhexedrine.
Nefazodone Nefazodone may increase the tachycardic activities of Propylhexedrine.
Milnacipran Milnacipran may increase the tachycardic activities of Propylhexedrine.
Desvenlafaxine Desvenlafaxine may increase the tachycardic activities of Propylhexedrine.
Levomilnacipran Levomilnacipran may increase the tachycardic activities of Propylhexedrine.
Ziprasidone The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Ziprasidone.
Amitriptyline The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Amitriptyline.
Olanzapine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Olanzapine.
Alfuzosin The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Alfuzosin.
Clozapine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Clozapine.
Promazine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Promazine.
Droperidol The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Droperidol.
Prazosin The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Prazosin.
Imipramine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Imipramine.
Chlorpromazine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Chlorpromazine.
Nortriptyline The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Nortriptyline.
Amoxapine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Amoxapine.
Doxazosin The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Doxazosin.
Labetalol The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Labetalol.
Nicardipine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Nicardipine.
Trazodone The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Trazodone.
Verapamil The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Verapamil.
Thioridazine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Thioridazine.
Phentolamine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Phentolamine.
Tamsulosin The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Tamsulosin.
Trimipramine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Trimipramine.
Risperidone The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Risperidone.
Propiomazine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Propiomazine.
Tolazoline The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Tolazoline.
Trifluoperazine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Trifluoperazine.
Flupentixol The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Flupentixol.
Quinidine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Quinidine.
Phenoxybenzamine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Phenoxybenzamine.
Carvedilol The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Carvedilol.
Doxepin The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Doxepin.
Terazosin The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Terazosin.
Quetiapine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Quetiapine.
Aripiprazole The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Aripiprazole.
Paliperidone The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Paliperidone.
Bevantolol The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Bevantolol.
Methotrimeprazine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Methotrimeprazine.
Periciazine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Periciazine.
Acepromazine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Acepromazine.
Thioproperazine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Thioproperazine.
Zuclopenthixol The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Zuclopenthixol.
Dronedarone The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Dronedarone.
Iloperidone The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Iloperidone.
Pizotifen The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Pizotifen.
Silodosin The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Silodosin.
Asenapine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Asenapine.
Indoramin The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Indoramin.
Brexpiprazole The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Brexpiprazole.
Trimazosin The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Trimazosin.
Niguldipine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Niguldipine.
Bunazosin The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Bunazosin.
Propiverine The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Propiverine.
Urapidil The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Urapidil.
Bucindolol The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Bucindolol.
Aripiprazole lauroxil The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Aripiprazole lauroxil.
Protriptyline The risk or severity of hypertension can be increased when Protriptyline is combined with Propylhexedrine.
Desipramine The risk or severity of hypertension can be increased when Desipramine is combined with Propylhexedrine.
Clomipramine The risk or severity of hypertension can be increased when Clomipramine is combined with Propylhexedrine.
Amineptine The risk or severity of hypertension can be increased when Amineptine is combined with Propylhexedrine.
Dimetacrine The risk or severity of hypertension can be increased when Dimetacrine is combined with Propylhexedrine.
Butriptyline The risk or severity of hypertension can be increased when Butriptyline is combined with Propylhexedrine.
Dosulepin The risk or severity of hypertension can be increased when Dosulepin is combined with Propylhexedrine.
Tianeptine The risk or severity of hypertension can be increased when Tianeptine is combined with Propylhexedrine.
Oxaprotiline The risk or severity of hypertension can be increased when Oxaprotiline is combined with Propylhexedrine.
Opipramol The risk or severity of hypertension can be increased when Opipramol is combined with Propylhexedrine.
Amitriptylinoxide The risk or severity of hypertension can be increased when Amitriptylinoxide is combined with Propylhexedrine.
Dibenzepin The risk or severity of hypertension can be increased when Dibenzepin is combined with Propylhexedrine.
Quinupramine The risk or severity of hypertension can be increased when Quinupramine is combined with Propylhexedrine.
Melitracen The risk or severity of hypertension can be increased when Melitracen is combined with Propylhexedrine.
Lofepramine The risk or severity of hypertension can be increased when Lofepramine is combined with Propylhexedrine.
Iprindole The risk or severity of hypertension can be increased when Iprindole is combined with Propylhexedrine.
Imipramine oxide The risk or severity of hypertension can be increased when Imipramine oxide is combined with Propylhexedrine.
Esmolol The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Esmolol.
Betaxolol The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Betaxolol.
Metoprolol The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Metoprolol.

Target Protein

Synaptic vesicular amine transporter SLC18A2
Alpha-2C adrenergic receptor ADRA2C
Trace amine-associated receptor 1 TAAR1

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 3 • International brands: 3
Produk
  • Benzedrex
    Inhalant • 175 mg/1 • Nasal • US • OTC
  • Benzedrex 09-19-2014
    Inhalant • 250 mg/1 • Nasal • US • OTC
  • Benzedrex Nasal Decongestant
    Inhalant • 250 mg/1 • Nasal • US • OTC
International Brands
  • Benzedrex
  • Dristan inhaler
  • Obesin

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul